🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for Crigler-Najjar Syndrome

Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome NCT06518005Phase 21 site📍 Clamart Genethon · Tests: Imlifidase, GNT0003 Gene Therapy for Crigler Najjar Syndrome Type I (AlphaCN) NCT06641154Phase 1, Phase 22 sites📍 Moscow📍 Moscow Federal State Budget Institution Research Center for Obstet… · Tests: GT-UGT1A1-AAV8-02 Gene Therapy for Severe Crigler Najjar Syndrome NCT03466463NA4 sites📍 Clamart📍 Bergamo📍 Naples Genethon · Tests: GNT0003
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy